54.09
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché AKRO Giù?
                                Forum
                                Previsione
                        
                        Akero Therapeutics Inc Borsa (AKRO) Ultime notizie
How high can Akero Therapeutics Inc. stock goEarnings Trend Report & Daily Growth Stock Tips - newser.com
Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsPortfolio Return Report & AI Powered Market Entry Ideas - newser.com
Heatmap analysis for Akero Therapeutics Inc. and competitorsJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is Akero Therapeutics Inc. (0K4) stock a contrarian opportunity - newser.com
Can Akero Therapeutics Inc. (0K4) stock beat analyst consensusJuly 2025 Movers & Reliable Entry Point Alerts - newser.com
Will Akero Therapeutics Inc. (0K4) stock rise with strong economyTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com
Is Akero Therapeutics Inc. stock a buy before product launchesWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Will Akero Therapeutics Inc. stock gain from lower inflationTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Can volume confirm reversal in Akero Therapeutics Inc.GDP Growth & Safe Entry Trade Reports - newser.com
How rising interest rates impact Akero Therapeutics Inc. stockCEO Change & AI Driven Price Predictions - newser.com
Can Akero Therapeutics Inc. (0K4) stock surprise with quarterly resultsWeekly Loss Report & Community Driven Trade Alerts - newser.com
Will Akero Therapeutics Inc. outperform the marketGap Down & Comprehensive Market Scan Insights - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Using RSI to spot recovery in Akero Therapeutics Inc.Gap Up & Expert Curated Trade Setups - newser.com
Chart based analysis of Akero Therapeutics Inc. trendsWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Is Akero Therapeutics Inc. stock a top pick in earnings seasonPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com
Jennison Associates LLC Grows Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Will Akero Therapeutics Inc. stock reach Wall Street targetsAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Y Intercept Hong Kong Ltd Takes Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Short Interest Update - MarketBeat
Fatty liver disease companies' multibillion-dollar deals mean fatter walletsSan Francisco Business Times - The Business Journals
Is Akero Therapeutics Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Return Opportunities - newser.com
Emerald Mutual Fund Advisers Trust Has $7.27 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat
Is Akero Therapeutics Inc. (0K4) stock included in top ETFsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Akero Therapeutics Inc. stock is recommended by analystsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Altimmune: Competitor Buyouts Plus Regulatory And Clinical Progress (NASDAQ:ALT) - Seeking Alpha
Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant - MSN
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):